220 related articles for article (PubMed ID: 24612842)
1. Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan.
Yoshino Y; Seo K; Koga I; Kitazawa T; Ota Y
Clin Respir J; 2015 Apr; 9(2):228-32. PubMed ID: 24612842
[TBL] [Abstract][Full Text] [Related]
2. A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults.
Ison MG; Hui DS; Clezy K; O'Neil BJ; Flynt A; Collis PJ; Simon TJ; Alexander WJ
Antivir Ther; 2013; 18(5):651-61. PubMed ID: 23111657
[TBL] [Abstract][Full Text] [Related]
3. Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza.
Yoo JW; Choi SH; Huh JW; Lim CM; Koh Y; Hong SB
J Med Virol; 2015 Oct; 87(10):1649-55. PubMed ID: 25946636
[TBL] [Abstract][Full Text] [Related]
4. Clinical effects of oseltamivir, zanamivir, laninamivir and peramivir on seasonal influenza infection in outpatients in Japan during the winter of 2012-2013.
Takemoto Y; Asai T; Ikezoe I; Yano T; Ichikawa M; Miyagawa S; Matsumoto J
Chemotherapy; 2013; 59(5):373-8. PubMed ID: 24821568
[TBL] [Abstract][Full Text] [Related]
5. Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.
Kohno S; Yen MY; Cheong HJ; Hirotsu N; Ishida T; Kadota J; Mizuguchi M; Kida H; Shimada J;
Antimicrob Agents Chemother; 2011 Nov; 55(11):5267-76. PubMed ID: 21825298
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis.
Lee J; Park JH; Jwa H; Kim YH
Yonsei Med J; 2017 Jul; 58(4):778-785. PubMed ID: 28540991
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study.
Zhang Y; Gao H; Liang W; Tang L; Yang Y; Wu X; Yu L; Chen P; Zheng S; Ou H; Li L
BMC Infect Dis; 2016 Feb; 16():76. PubMed ID: 26864456
[TBL] [Abstract][Full Text] [Related]
8. Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4-12 years): an open-label, randomized study in Japan.
Hirotsu N; Saisho Y; Hasegawa T; Shishido T
Expert Rev Anti Infect Ther; 2018 Feb; 16(2):173-182. PubMed ID: 29284320
[TBL] [Abstract][Full Text] [Related]
9. Intravenous peramivir for treatment of influenza in hospitalized patients.
Ison MG; Fraiz J; Heller B; Jauregui L; Mills G; O'Riordan W; O'Neil B; Playford EG; Rolf JD; Sada-Diaz E; Elder J; Collis P; Hernandez JE; Sheridan WP
Antivir Ther; 2014; 19(4):349-61. PubMed ID: 23985625
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients.
de Jong MD; Ison MG; Monto AS; Metev H; Clark C; O'Neil B; Elder J; McCullough A; Collis P; Sheridan WP
Clin Infect Dis; 2014 Dec; 59(12):e172-85. PubMed ID: 25115871
[TBL] [Abstract][Full Text] [Related]
11. Effects of corticosteroid and neuraminidase inhibitors on survival in patients with respiratory distress induced by influenza virus.
Huang SF; Fung CP; Perng DW; Wang FD
J Microbiol Immunol Infect; 2017 Oct; 50(5):586-594. PubMed ID: 26542650
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of laninamivir and peramivir in patients with seasonal influenza: a randomized clinical trial.
Yoshino Y; Seo K; Koga I; Kitazawa T; Ota Y
Infect Dis (Lond); 2017 May; 49(5):417-419. PubMed ID: 27766921
[No Abstract] [Full Text] [Related]
13. Intravenous peramivir vs oral oseltamivir in high-risk emergency department patients with influenza: Results from a pilot randomized controlled study.
Hsieh YH; Dugas AF; LoVecchio F; McBryde B; Ricketts EP; Saliba-Shaw K; Rothman RE
Influenza Other Respir Viruses; 2021 Jan; 15(1):121-131. PubMed ID: 33006445
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficiency in children treated with intravenous drip infusion of peramivir].
Sakata H
Jpn J Antibiot; 2011 Dec; 64(6):383-7. PubMed ID: 22686008
[TBL] [Abstract][Full Text] [Related]
15. Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan.
Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Oba K; Togashi T; Morita K; Inagawa A; Okamura A; Yamazaki S; Shida S; Konno M; Kawamura N; Ishizaka A; Takada K; Tsubakihara K; Nagano N; Shibata M; Furuyama H; Matsuzono Y; Koike A; Murashita M; Hatae Y; Arioka H; Yamanaka T; Watanabe T; Tabata Y; Kumita Y; Hazama K; Akutsu Y; Aoyagi H; Tobise C; Azuma K; Yasoshima K; Sawada Y; Uetsuji K; Tsuchida A; Tsuchiyama A; Yasuda K; Odagawa Y; Yoshioka M
J Infect Chemother; 2018 Jun; 24(6):449-457. PubMed ID: 29487035
[TBL] [Abstract][Full Text] [Related]
16. Peramivir and its use in H1N1 influenza.
Castillo R; Holland LE; Boltz DA
Drugs Today (Barc); 2010 Jun; 46(6):399-408. PubMed ID: 20571608
[TBL] [Abstract][Full Text] [Related]
17. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
Mancuso CE; Gabay MP; Steinke LM; Vanosdol SJ
Ann Pharmacother; 2010; 44(7-8):1240-9. PubMed ID: 20516360
[TBL] [Abstract][Full Text] [Related]
18. [Current anti-influenza virus chemotherapy].
Yoshioka D; Tokimatsu I; Ishii H; Kadota J
Nihon Rinsho; 2010 Sep; 68(9):1679-84. PubMed ID: 20845747
[TBL] [Abstract][Full Text] [Related]
19. [A randomized controlled study of peramivir, oseltamivir and placebo in patients with mild influenza].
Fan HW; Han Y; Liu W; Li XW; Li LZ; Yao HY; Wang Y; Su ZQ; Ye WX; Huang J; Lu WZ; Li GW; Li HL; Wang SY; Wu H; Lu QF; Zhu GF; Liu SM; Chen G; Zhang WH; Li TS
Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):560-565. PubMed ID: 31365976
[No Abstract] [Full Text] [Related]
20. Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigation.
Komeda T; Ishii S; Itoh Y; Ariyasu Y; Sanekata M; Yoshikawa T; Shimada J
J Infect Chemother; 2015 Mar; 21(3):194-201. PubMed ID: 25523716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
